Compare $ASMB vs $DMAC | Chartloom

Compare

$ASMB vs $DMAC

Assembly Biosciences Inc · DiaMedica Therapeutics Inc

ASMB

Assembly Biosciences Inc

DMAC

DiaMedica Therapeutics Inc

Compare $ASMB vs $DMAC

Comparing Assembly Biosciences Inc and DiaMedica Therapeutics Inc

ASMBAssembly Biosciences Inc

DMACDiaMedica Therapeutics Inc

ASMBAssembly Biosciences Inc

Market cap

$466M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

17.93x

Rev growth (TTM)

125.1%

YTD performance

-30.3%

52W performance

-7.7%

FCF yield

-8.3%

DMACDiaMedica Therapeutics Inc

Market cap

$449M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

5.0%

52W performance

19.7%

FCF yield

-7.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ASMB

DMAC

Detailed metrics comparison

ASMB

Assembly Biosciences Inc

DMAC

DiaMedica Therapeutics Inc

Market Cap

ASMB$466M

DMAC$449M

Enterprise Value

ASMB$434M

DMAC$444M

Price

ASMB$23.53

DMAC$8.33

P/E Ratio

ASMBN/A

DMACN/A

P/S Ratio

ASMB6.23x

DMAC0.00x

EV/Sales

ASMB5.80x

DMAC0.00x

EV/EBITDA

ASMB0.00x

DMAC0.00x

P/B Ratio

ASMB1.50x

DMAC11.58x

P/FCF Ratio

ASMBN/A

DMACN/A

EV/FCF

ASMB-11.26x

DMAC-14.07x

PEG Ratio

ASMBN/A

DMACN/A

Forward P/E (NTM)

ASMBN/A

DMACN/A

Forward P/S (NTM)

ASMB17.93x

DMACN/A

Revenue (TTM)

ASMB$75M

DMAC$0

Revenue Growth (YoY)

ASMB125.1%

DMACN/A

Forward Rev Growth

ASMB2.1%

DMAC306.4%

Gross Margin (TTM)

ASMB0.0%

DMAC0.0%

Operating Margin (TTM)

ASMB0.0%

DMAC0.0%

EBITDA Margin (TTM)

ASMB-11.6%

DMAC0.0%

Net Margin (TTM)

ASMB-0.1%

DMAC0.0%

FCF Margin (TTM)

ASMB-51.5%

DMACN/A

Net Income (TTM)

ASMB$-42K

DMAC$-38M

FCF (TTM)

ASMB$-39M

DMAC$-32M

EPS (TTM)

ASMB-$0.00

DMAC-$0.70

ROE (TTM)

ASMB-2.0%

DMAC-7768.0%

ROA (TTM)

ASMB-2.0%

DMAC-6936.0%

ROIC (TTM)

ASMB-2.0%

DMAC-7766.0%

Cash

ASMB$32M

DMAC$5M

Debt

ASMB$0

DMAC$9K

Net Cash/Debt

ASMB$32M

DMAC$5M

Current Ratio (TTM)

ASMB13.99x

DMAC6.72x

Quick Ratio (TTM)

ASMB13.70x

DMAC6.63x

Debt/Equity (TTM)

ASMB0.00x

DMAC0.00x

Debt/Assets (TTM)

ASMB0.0%

DMAC0.0%

Interest Coverage (TTM)

ASMBN/A

DMACN/A

Net Debt/EBITDA (TTM)

ASMB0.00x

DMAC0.00x

Beta

ASMB1.21

DMAC0.96

52W Performance

ASMB-7.7%

DMAC19.7%

YTD Performance

ASMB-30.3%

DMAC5.0%

% from 52W High

ASMB-40.7%

DMAC-20.1%

% from 52W Low

ASMB8.0%

DMAC58.8%

Asset Turnover (TTM)

ASMB0.28x

DMAC0.00x

FCF Yield (TTM)

ASMB-8.3%

DMAC-7.0%

Earnings Yield (TTM)

ASMB-0.0%

DMAC-8.4%

Dividend Yield (TTM)

ASMBN/A

DMACN/A

Rule of 40

ASMB73.6

DMAC0.0

EV/GP/RG

ASMBN/A

DMACN/A

Ticker research

View ASMB research View DMAC research

Metric	ASMB Assembly Biosciences Inc	DMAC DiaMedica Therapeutics Inc
Market & Valuation
Market Cap	$466M	$449M
Enterprise Value	$434M	$444M
Price	$23.53	$8.33
P/E Ratio	N/A	N/A
P/S Ratio	6.23x	0.00x
EV/Sales	5.80x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.50x	11.58x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.26x	-14.07x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	17.93x	N/A
Revenue & Growth
Revenue (TTM)	$75M	$0
Revenue Growth (YoY)	125.1%	N/A
Forward Rev Growth	2.1%	306.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-11.6%	0.0%
Net Margin (TTM)	-0.1%	0.0%
FCF Margin (TTM)	-51.5%	N/A
Net Income (TTM)	$-42K	$-38M
FCF (TTM)	$-39M	$-32M
EPS (TTM)	-$0.00	-$0.70
ROE (TTM)	-2.0%	-7768.0%
ROA (TTM)	-2.0%	-6936.0%
ROIC (TTM)	-2.0%	-7766.0%
Financial Health
Cash	$32M	$5M
Debt	$0	$9K
Net Cash/Debt	$32M	$5M
Current Ratio (TTM)	13.99x	6.72x
Quick Ratio (TTM)	13.70x	6.63x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	0.96
52W Performance	-7.7%	19.7%
YTD Performance	-30.3%	5.0%
% from 52W High	-40.7%	-20.1%
% from 52W Low	8.0%	58.8%
Efficiency & Yields
Asset Turnover (TTM)	0.28x	0.00x
FCF Yield (TTM)	-8.3%	-7.0%
Earnings Yield (TTM)	-0.0%	-8.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	73.6	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ASMB research	View DMAC research

Valuation

P/S Ratio

DMAC

0.00x

ASMB

6.23x

EV/FCF

DMAC

-14.07x

ASMB

-11.26x

Growth & revenue

Revenue Growth TTM

ASMB

125.1%

Forward Revenue Growth

DMAC

306.4%

ASMB

2.1%

Profitability & performance

Gross Margin

ASMB

0.0%

DMAC

0.0%

ROE

ASMB

-2.0%

DMAC

-7768.0%

FCF Yield %

DMAC

-7.0%

ASMB

-8.3%

52-Week Performance

DMAC

19.7%

ASMB

-7.7%

Detailed metrics comparison

ASMB

Assembly Biosciences Inc

DMAC

DiaMedica Therapeutics Inc

Market Cap

ASMB$466M

DMAC$449M

Enterprise Value

ASMB$434M

DMAC$444M

Price

ASMB$23.53

DMAC$8.33

P/E Ratio

ASMBN/A

DMACN/A

P/S Ratio

ASMB6.23x

DMAC0.00x

EV/Sales

ASMB5.80x

DMAC0.00x

EV/EBITDA

ASMB0.00x

DMAC0.00x

P/B Ratio

ASMB1.50x

DMAC11.58x

P/FCF Ratio

ASMBN/A

DMACN/A

EV/FCF

ASMB-11.26x

DMAC-14.07x

PEG Ratio

ASMBN/A

DMACN/A

Forward P/E (NTM)

ASMBN/A

DMACN/A

Forward P/S (NTM)

ASMB17.93x

DMACN/A

Revenue (TTM)

ASMB$75M

DMAC$0

Revenue Growth (YoY)

ASMB125.1%

DMACN/A

Forward Rev Growth

ASMB2.1%

DMAC306.4%

Gross Margin (TTM)

ASMB0.0%

DMAC0.0%

Operating Margin (TTM)

ASMB0.0%

DMAC0.0%

EBITDA Margin (TTM)

ASMB-11.6%

DMAC0.0%

Net Margin (TTM)

ASMB-0.1%

DMAC0.0%

FCF Margin (TTM)

ASMB-51.5%

DMACN/A

Net Income (TTM)

ASMB$-42K

DMAC$-38M

FCF (TTM)

ASMB$-39M

DMAC$-32M

EPS (TTM)

ASMB-$0.00

DMAC-$0.70

ROE (TTM)

ASMB-2.0%

DMAC-7768.0%

ROA (TTM)

ASMB-2.0%

DMAC-6936.0%

ROIC (TTM)

ASMB-2.0%

DMAC-7766.0%

Cash

ASMB$32M

DMAC$5M

Debt

ASMB$0

DMAC$9K

Net Cash/Debt

ASMB$32M

DMAC$5M

Current Ratio (TTM)

ASMB13.99x

DMAC6.72x

Quick Ratio (TTM)

ASMB13.70x

DMAC6.63x

Debt/Equity (TTM)

ASMB0.00x

DMAC0.00x

Debt/Assets (TTM)

ASMB0.0%

DMAC0.0%

Interest Coverage (TTM)

ASMBN/A

DMACN/A

Net Debt/EBITDA (TTM)

ASMB0.00x

DMAC0.00x

Beta

ASMB1.21

DMAC0.96

52W Performance

ASMB-7.7%

DMAC19.7%

YTD Performance

ASMB-30.3%

DMAC5.0%

% from 52W High

ASMB-40.7%

DMAC-20.1%

% from 52W Low

ASMB8.0%

DMAC58.8%

Asset Turnover (TTM)

ASMB0.28x

DMAC0.00x

FCF Yield (TTM)

ASMB-8.3%

DMAC-7.0%

Earnings Yield (TTM)

ASMB-0.0%

DMAC-8.4%

Dividend Yield (TTM)

ASMBN/A

DMACN/A

Rule of 40

ASMB73.6

DMAC0.0

EV/GP/RG

ASMBN/A

DMACN/A

Ticker research

View ASMB research View DMAC research

Metric	ASMB Assembly Biosciences Inc	DMAC DiaMedica Therapeutics Inc
Market & Valuation
Market Cap	$466M	$449M
Enterprise Value	$434M	$444M
Price	$23.53	$8.33
P/E Ratio	N/A	N/A
P/S Ratio	6.23x	0.00x
EV/Sales	5.80x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.50x	11.58x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.26x	-14.07x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	17.93x	N/A
Revenue & Growth
Revenue (TTM)	$75M	$0
Revenue Growth (YoY)	125.1%	N/A
Forward Rev Growth	2.1%	306.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-11.6%	0.0%
Net Margin (TTM)	-0.1%	0.0%
FCF Margin (TTM)	-51.5%	N/A
Net Income (TTM)	$-42K	$-38M
FCF (TTM)	$-39M	$-32M
EPS (TTM)	-$0.00	-$0.70
ROE (TTM)	-2.0%	-7768.0%
ROA (TTM)	-2.0%	-6936.0%
ROIC (TTM)	-2.0%	-7766.0%
Financial Health
Cash	$32M	$5M
Debt	$0	$9K
Net Cash/Debt	$32M	$5M
Current Ratio (TTM)	13.99x	6.72x
Quick Ratio (TTM)	13.70x	6.63x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	0.96
52W Performance	-7.7%	19.7%
YTD Performance	-30.3%	5.0%
% from 52W High	-40.7%	-20.1%
% from 52W Low	8.0%	58.8%
Efficiency & Yields
Asset Turnover (TTM)	0.28x	0.00x
FCF Yield (TTM)	-8.3%	-7.0%
Earnings Yield (TTM)	-0.0%	-8.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	73.6	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ASMB research	View DMAC research